Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Tolvaptan to Treat SIADH-induced Hyponatremia in Selected Patients With Acute Neurological Injuries

NCT02545114 is registered in ClinicalTrials.gov with Polderman, Kees, H., MD, PhD as lead sponsor.

NCT NCT02545114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02545114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Tolvaptan to Treat SIADH-induced Hyponatremia in Selected Patients With Acute Neurological Injuries
Lead sponsor
Polderman, Kees, H., MD, PhD
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2015
Completion date
September 30, 2016
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyponatremia, siadh